Correlation Between Lumos Pharma and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lumos Pharma and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lumos Pharma and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lumos Pharma and Candel Therapeutics, you can compare the effects of market volatilities on Lumos Pharma and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lumos Pharma with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lumos Pharma and Candel Therapeutics.
Diversification Opportunities for Lumos Pharma and Candel Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Lumos and Candel is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Lumos Pharma and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Lumos Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lumos Pharma are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Lumos Pharma i.e., Lumos Pharma and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Lumos Pharma and Candel Therapeutics
If you would invest 917.00 in Candel Therapeutics on December 25, 2024 and sell it today you would lose (51.00) from holding Candel Therapeutics or give up 5.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Lumos Pharma vs. Candel Therapeutics
Performance |
Timeline |
Lumos Pharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Candel Therapeutics |
Lumos Pharma and Candel Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lumos Pharma and Candel Therapeutics
The main advantage of trading using opposite Lumos Pharma and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lumos Pharma position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics | Lumos Pharma vs. Silo Pharma |
Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |